BPC-157 3mg/mL (5mL)

BPC-157 3 mg/mL (5 mL) refers to a research peptide solution containing Body Protection Compound-157 (BPC-157), a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice. It is studied for its tissue-protective and healing properties in preclinical research but is not approved by the U.S. Food and Drug Administration for medical use in humans. (turn0search1 ) BPC-157 has been investigated extensively in animal and laboratory studies, where it demonstrated angiogenic, cytoprotective, and wound-healing effects. For example, it promoted healing of tendons, muscles, ligaments, and bone in rodent models and enhanced vascular responses after injury. (turn0search5 ) Preclinical research also suggests protective effects on organs such as the liver, kidneys, and lungs following ischemic injury. (turn0search20 ) Mechanistically, BPC-157 may influence angiogenesis (blood vessel formation) and modulate signaling pathways involved in cell survival and repair. Reviews of vascular studies indicate that BPC-157 acts as a potent angiomodulatory agent in various injury models. (turn0search3 ) Despite encouraging preclinical results, robust human clinical evidence is limited, and health authorities caution that more research is needed to confirm safety and efficacy in humans. Some clinical trials have explored safety in inflammatory bowel disease and other conditions, but widespread therapeutic use is not established. (turn0search7 ) Links for more information: Preclinical healing effects: https://pmc.ncbi.nlm.nih.gov/articles/PMC6271067/ Vascular injury and angiogenesis review: https://pubmed.ncbi.nlm.nih.gov/23782145/